435 related articles for article (PubMed ID: 17331707)
1. Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment.
de Assis Santos D; de Carvalho Araújo RA; Kohler LM; Machado-Pinto J; Hamdan JS; Cisalpino PS
Int J Antimicrob Agents; 2007 May; 29(5):563-9. PubMed ID: 17331707
[TBL] [Abstract][Full Text] [Related]
2. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
Bradley MC; Leidich S; Isham N; Elewski BE; Ghannoum MA
Mycoses; 1999; 42 Suppl 2():105-10. PubMed ID: 10865915
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes.
Santos DA; Hamdan JS
Med Mycol; 2006 Jun; 44(4):357-62. PubMed ID: 16772230
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole.
Santos DA; Hamdan JS
Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Sarifakioglu E; Seçkin D; Demirbilek M; Can F
Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
[TBL] [Abstract][Full Text] [Related]
6. Determination of susceptibility/resistance to antifungal drugs of Trichophyton mentagrophytes isolates by a macrodilution method.
Barros ME; Hamdan JS
Can J Microbiol; 2005 Nov; 51(11):983-7. PubMed ID: 16333338
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility and genetic similarity of sequential isolates of Trichophyton rubrum from an immunocompetent patient with chronic dermatophytosis.
Cordeiro RA; Brilhante RS; Rocha MF; Rabenhorsch SH; Moreira JL; Grangeiro TB; Sidrim JJ
Clin Exp Dermatol; 2006 Jan; 31(1):122-4. PubMed ID: 16309501
[TBL] [Abstract][Full Text] [Related]
8. Trichophyton rubrum DNA strain switching increases in patients with onychomycosis failing antifungal treatments.
Gupta AK; Nakrieko KA
Br J Dermatol; 2015 Jan; 172(1):74-80. PubMed ID: 24903451
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
[TBL] [Abstract][Full Text] [Related]
10. Fast and sensitive detection of Trichophyton rubrum DNA from the nail samples of patients with onychomycosis by a double-round polymerase chain reaction-based assay.
Gupta AK; Zaman M; Singh J
Br J Dermatol; 2007 Oct; 157(4):698-703. PubMed ID: 17714569
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibility testing of Trichophyton rubrum by E-test.
da Silva Barros ME; de Assis Santos D; Soares Hamdan J
Arch Dermatol Res; 2007 May; 299(2):107-9. PubMed ID: 17333224
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A).
Barros MEDS; Santos DA; Hamdan JS
J Med Microbiol; 2007 Apr; 56(Pt 4):514-518. PubMed ID: 17374893
[TBL] [Abstract][Full Text] [Related]
13. Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes.
Santos DA; Barros ME; Hamdan JS
J Clin Microbiol; 2006 Jan; 44(1):98-101. PubMed ID: 16390955
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S
Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum.
Fernández-Torres B; Vázquez-Veiga H; Llovo X; Pereiro M; Guarro J
Chemotherapy; 2000; 46(6):390-4. PubMed ID: 11053904
[TBL] [Abstract][Full Text] [Related]
16. Onychomycosis: clinical, mycological and in vitro susceptibility testing of isolates of Trichophyton rubrum.
Azambuja CV; Pimmel LA; Klafke GB; Xavier MO
An Bras Dermatol; 2014; 89(4):581-6. PubMed ID: 25054744
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum.
Santos DA; Hamdan JS
J Clin Microbiol; 2005 Apr; 43(4):1917-20. PubMed ID: 15815018
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the in vitro susceptibility pattern of clinical isolates of Trichophyton mentagrophytes and Trichophyton rubrum in Santiago, Chile].
Díaz Jarabrán MC; Díaz González P; Espinoza Rodríguez J; Carrillo Muñoz AJ
Rev Iberoam Micol; 2015; 32(2):83-7. PubMed ID: 24794211
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of Trichophyton tonsurans strains isolated in Japan between 2006 and 2010 and their susceptibility to oral antimycotics.
Anzawa K; Mochizuki T; Nishibu A; Ishizaki H; Kamei K; Takahashi Y; Fujihiro M; Shinoda H
Jpn J Infect Dis; 2011; 64(6):458-62. PubMed ID: 22116323
[TBL] [Abstract][Full Text] [Related]
20. Molecular typing of Trichophyton rubrum clinical isolates from Poland.
Hryncewicz-Gwóźdź A; Jagielski T; Sadakierska-Chudy A; Dyląg M; Pawlik K; Baran E; Szepietowski JC
Mycoses; 2011 Nov; 54(6):e726-36. PubMed ID: 21917026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
